Picture of Arix Bioscience logo

ARIX Arix Bioscience Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeSmall CapMomentum Trap

Annual cashflow statement for Arix Bioscience, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line42.8-75.6126-61.1-27.6
Depreciation
Non-Cash Items-53.167.1-13355.122.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.19-0.4850.118-1.4-0.114
Change in Accounts Receivable
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-11.1-8.47-6.73-7.14-4.64
Capital Expenditures-0.002-0.006-0.007-0.101-0.008
Purchase of Fixed Assets
Other Investing Cash Flow Items-11534.166.342.1-12.8
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-11534.166.342-12.8
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities82.2-0.9860-11.6-0.063
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-43.923.657.422.1-11.4